Earlier research revealed that the impaired function of NK-T-B-antigen (NTB-A, CD352) is pivotal in the failure of XLP-NK cells to eliminate EBV-infected target cells (72). Here, SLAMF6 is linked to X-linked lymphoproliferative disease.